Women's Health Resources
Featured Centers
- Eating Out? Cut Calories, Heartburn
- 5 Good Ways to Save Money on Medicine
- 8 Ways to Treat Your Allergies
*Urinary incontinence (UI) in men facts Medically Edited by: Melissa Conrad Stöppler, MD
|
|
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
OXYTROL (oxybutynin transdermal) is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.
Read the complete drug monograph for Oxytrol »
Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More
What is Patient information?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using oxybutynin transdermal and call your doctor at once if you have any of these serious side effects:
Less serious side effects may include...
Read the complete patient information for Oxytrol »
Possible Side Effects - Images - What Is - How Should I Take It - What If I Miss a Dose - What Should I Avoid and More
What is Consumer information?
A concise overview of the drug for the patient or caregiver from First DataBank.
This medication is not recommended for use in children younger than 5 years of age. Consult your doctor for more information.
HOW TO USE: Read the Patient Information Leaflet provided by your pharmacist...
Read the complete consumer information for Oxytrol »
Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.